Cargando…

P1039: LOW DOSE CYTARABINE FOR ADULT PATIENTS WITH NEWLY DIAGNOSED LANGERHANS CELL HISTIOCYTOSIS: A SINGLE ARM, SINGLE CENTER, PROSPECTIVE PHASE 2 STUDY

Detalles Bibliográficos
Autores principales: Chang, Long, Lang, Min, Duan, Minghui, LI, Jian, Zhou, Dao-Bin, Cao, Xin-Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431420/
http://dx.doi.org/10.1097/01.HS9.0000971052.20461.da
_version_ 1785091196565061632
author Chang, Long
Lang, Min
Duan, Minghui
LI, Jian
Zhou, Dao-Bin
Cao, Xin-Xin
author_facet Chang, Long
Lang, Min
Duan, Minghui
LI, Jian
Zhou, Dao-Bin
Cao, Xin-Xin
author_sort Chang, Long
collection PubMed
description
format Online
Article
Text
id pubmed-10431420
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104314202023-08-17 P1039: LOW DOSE CYTARABINE FOR ADULT PATIENTS WITH NEWLY DIAGNOSED LANGERHANS CELL HISTIOCYTOSIS: A SINGLE ARM, SINGLE CENTER, PROSPECTIVE PHASE 2 STUDY Chang, Long Lang, Min Duan, Minghui LI, Jian Zhou, Dao-Bin Cao, Xin-Xin Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431420/ http://dx.doi.org/10.1097/01.HS9.0000971052.20461.da Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Chang, Long
Lang, Min
Duan, Minghui
LI, Jian
Zhou, Dao-Bin
Cao, Xin-Xin
P1039: LOW DOSE CYTARABINE FOR ADULT PATIENTS WITH NEWLY DIAGNOSED LANGERHANS CELL HISTIOCYTOSIS: A SINGLE ARM, SINGLE CENTER, PROSPECTIVE PHASE 2 STUDY
title P1039: LOW DOSE CYTARABINE FOR ADULT PATIENTS WITH NEWLY DIAGNOSED LANGERHANS CELL HISTIOCYTOSIS: A SINGLE ARM, SINGLE CENTER, PROSPECTIVE PHASE 2 STUDY
title_full P1039: LOW DOSE CYTARABINE FOR ADULT PATIENTS WITH NEWLY DIAGNOSED LANGERHANS CELL HISTIOCYTOSIS: A SINGLE ARM, SINGLE CENTER, PROSPECTIVE PHASE 2 STUDY
title_fullStr P1039: LOW DOSE CYTARABINE FOR ADULT PATIENTS WITH NEWLY DIAGNOSED LANGERHANS CELL HISTIOCYTOSIS: A SINGLE ARM, SINGLE CENTER, PROSPECTIVE PHASE 2 STUDY
title_full_unstemmed P1039: LOW DOSE CYTARABINE FOR ADULT PATIENTS WITH NEWLY DIAGNOSED LANGERHANS CELL HISTIOCYTOSIS: A SINGLE ARM, SINGLE CENTER, PROSPECTIVE PHASE 2 STUDY
title_short P1039: LOW DOSE CYTARABINE FOR ADULT PATIENTS WITH NEWLY DIAGNOSED LANGERHANS CELL HISTIOCYTOSIS: A SINGLE ARM, SINGLE CENTER, PROSPECTIVE PHASE 2 STUDY
title_sort p1039: low dose cytarabine for adult patients with newly diagnosed langerhans cell histiocytosis: a single arm, single center, prospective phase 2 study
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431420/
http://dx.doi.org/10.1097/01.HS9.0000971052.20461.da
work_keys_str_mv AT changlong p1039lowdosecytarabineforadultpatientswithnewlydiagnosedlangerhanscellhistiocytosisasinglearmsinglecenterprospectivephase2study
AT langmin p1039lowdosecytarabineforadultpatientswithnewlydiagnosedlangerhanscellhistiocytosisasinglearmsinglecenterprospectivephase2study
AT duanminghui p1039lowdosecytarabineforadultpatientswithnewlydiagnosedlangerhanscellhistiocytosisasinglearmsinglecenterprospectivephase2study
AT lijian p1039lowdosecytarabineforadultpatientswithnewlydiagnosedlangerhanscellhistiocytosisasinglearmsinglecenterprospectivephase2study
AT zhoudaobin p1039lowdosecytarabineforadultpatientswithnewlydiagnosedlangerhanscellhistiocytosisasinglearmsinglecenterprospectivephase2study
AT caoxinxin p1039lowdosecytarabineforadultpatientswithnewlydiagnosedlangerhanscellhistiocytosisasinglearmsinglecenterprospectivephase2study